Cornea and external disease

FDA approves Verkazia for treatment of vernal keratoconjunctivitis

The U.S. Food and Drug Administration has approved Verkazia (cyclosporine ophthalmic emulsion; Santen Inc) 0.1% eye drops for the treatment of vernal keratoconjunctivitis (VKC) in children and adults, according to a press release. “This is an important milestone in Santen’s aim to bring innovative solutions that protect vision for those...